Managing Fibromyalgia Pain and Depression – Cymbalta Fibromyalgia Treatments for Depression
Cymbalta, which is an antidepressant, is believed to reduce depression and is also considered to be a possible benefit to women suffering from Fibromyalgia. This illness, which is still considered rare even though it affects millions of Americans, affects more women and men. Even though the cause of it remains unknown, Fibromyalgia is a growing problem that many are forced to cope with on a daily basis.
A Cymbalta Fibromyalgia treatment is designed to help treat both the emotional and physical symptoms of depression. In general, individuals who are dealing with a chronic illness often become depressed and sometimes turn to the world of medicine for assistance.
It is important to note that Cymbalta is not approved for the treatment of Fibromyalgia, but studies have found that it could be beneficial in depression. Because it is thought to help treat depression, which is often the result of a chronic illness, some experts believe that there are benefits that coincide with this illness and a Cymbalta Fibromyalgia treatment.
Cymbalta Fibromyalgia treatments can cause various side effects with the most common being nausea, constipation, dry mouth, decreased appetite, etc. Cymbalta is not for everyone, especially to those who are allergic to its ingredients.
In addition, individuals with liver or kidney problems, have been diagnosed with glaucoma or consume large amounts of alcohol should speak with their physician prior to taking Cymbalta. Women who are pregnant or nursing should not take Cymbalta and should make their physician aware of any conditions prior to accepting any type of prescription.
Prior to accepting any type of prescription medication, individuals must make sure that their physician is made fully aware of any medicines that are currently being consumed and/or any current illnesses. In order to safely provide treatments, a physician must be made fully aware of the circumstances surrounding the patient’s health.
Patients who are being treated for depression should be monitored closely in order to ensure that the depression does not worsen or become increasingly dangerous to the patient. Individuals who are severely depressed may require hospitalization and extended care beyond that which a prescription-based medicine can offer. Anyone who feels that their depression is worsening should consult their physician for a proper diagnosis and a recommended treatment course.
Managing Fibromyalgia Pain and Depression – Lyrica for Fibromyalgia
Lyrica, also known as pregabalin derived from a prohibited neurotransmitter, gamma-aminobutyric acid (GABA).
Lyrica has been standardised by the FDA for diabetic nerve ache and post-therapeutic nerve ache. Lyrica connects to calcium path in the central nervous system. Its outcome is realised due to its ability to trim down the calcium dependent release of several neurotransmitters.
Researchers at the University of Michigan assessed the efficiency and security of pregabalin for the treatment of fibromyalgia (FM) in an eight-week, placebo-controlled, phase II test. The patients were given with pregabalin doses of 150mg, 300mg, or 450mg per day or with a placebo.
The total dosage was fragmented into three doses a day and consumed for eight weeks. After a one-week baseline-watching period, the primary measurement of efficiency was the pain level at the end of the eight weeks. This information was taken from daily ache diaries.
Patients treated with Lyrica had statistically momentous improvement in their average pain score contrasted with the placebo. The patients who are treated with Lyrica, 28.9 percent had a statistically noteworthy (greater than 50 percent) drop in pain from baseline matched up to 13.2 percent of patients treated with the placebo.
Forty-eight percent of patients in the Lyrica of the 450mg per day group had at least a 30 percent statistically momentous fall in pain from baseline compared to 27 percent on the placebo. The significant progress in pain happened as early as week one.
There were major improvements in practical ways such as sleep, fatigue, and activity of life. The most common treatment events were drowsiness and faintness and were considered to be dose related. Discontinuous rates owed to side effects were less than 10 percent.
Fibromyalgia experts have used Lyrica in practice and more medical information regarding its effect on Fibromyalgia is yet to come out.
The information in this article is to be used for informational purposes only. It should not be used in place of, or in conjunction with, professional medical advice. Anyone with questions regarding a Cymbalta Fibromyalgia treatment or Lyrica for fibromyalgia must consult their physician for further information.
For more ideas on managing fibromyalgia pain and depression, watch these 2 videos-
25 Min Stretch Routine To Reduce Chronic Pain- Great for Fibromyalgia
Managing Chronic Pain and Depression
This article is from the Get Your Health Back – Fibromyalgia & Chronic Fatigue Freedom. It consists of a strategy filled with guides on sleep, pain, depression, anxiety, diet, exercise and fitness plans, diet plans and packed with 369 healthy and delicious recipes
To find out more about this program, visit the website – Get Your Health Back – Fibromyalgia & Chronic Fatigue Freedom
11 Replies to “Managing Fibromyalgia Pain and Depression – What You Need to Know”